FDA Inspection
Cerovene Inc.Cerovene Inc. – FDA Inspection, Apr 28, 2025
Record Details
This FDA Inspection record concerns Cerovene Inc., with an inspection on April 28, 2025, issued by the New York District Office, covering human drugs.
View Company Profile
ID · ca8c9d19-4154-4d01-97d9-b1defafb20b3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1269142
- FDA center
- Human Drugs
- Project area
- Generic Drug Evaluation
FDA Citations
3- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.68(b)Computer control of master formula records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Cerovene Inc.
10| Date | Classification | Office | Project area |
|---|---|---|---|
| March 23, 2026 | Not classified | New York District Office | |
| August 1, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 5, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 6, 2017 | Not classified | New York District Office | |
| February 8, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Cerovene Inc.
- FDA Inspection 1308838 - 2026-03-23
- FDA Inspection 1215341 - 2023-08-01
- FDA Inspection 1074159 - 2018-11-05
- FDA Inspection 1030876 - 2017-11-06
- FDA Inspection 1001439 - 2017-02-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.